Chemotherapy Resistance

Overview

Chemotherapy resistance is a term used to describe the diminished effectiveness of chemotherapy drugs, which are used to treat cancer. Some cancer cells become resistant to the effects of chemotherapy drugs and can continue to survive and multiply even after being exposed to these drugs. Understanding the mechanisms of chemotherapy resistance is an important area of research in cancer treatments, as it helps clinicians to better select and tailor chemotherapy treatments for cancer patients and improve their outcomes. Research has also been conducted to develop new types of chemotherapy drugs that can be used to combat chemotherapy resistance.

Research published in this journal

2 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 2 articles above have been cited 3 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.

• Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer
  Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
• J591 functionalized paclitaxel loaded PLGA nanoparticles successfully inhibited PSMA overexpressing LNCaP cells
  Iman Ehsan et al. · 2022 · Journal of Drug Delivery Science and Technology
• Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
  2019 · Journal of Experimental and Clinical Toxicology

A sample of recent works citing this journal's research on Chemotherapy Resistance, linking to each citing work.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics